You can:
Name | Type-1 angiotensin II receptor |
---|---|
Species | Oryctolagus cuniculus (Rabbit) |
Gene | AGTR1 |
Synonym | Angiotensin II type-1 receptor AT1 |
Disease | N/A for non-human GPCRs |
Length | 359 |
Amino acid sequence | MMLNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLAVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWVPHQIFTFLDVLIQLGVIHDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKKYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSSKKPVPCFEVE |
UniProt | P34976 |
Protein Data Bank | N/A |
GPCR-HGmod model | N/A |
3D structure model | No available structures or models |
BioLiP | N/A |
Therapeutic Target Database | N/A |
ChEMBL | CHEMBL3948 |
IUPHAR | N/A |
DrugBank | N/A |
Name | CHEMBL315469 |
---|---|
Molecular formula | C23H25N7O3 |
IUPAC name | 2-[3-butyl-5-oxo-4-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,2,4-triazol-1-yl]propanoic acid |
Molecular weight | 447.499 |
Hydrogen bond acceptor | 7 |
Hydrogen bond donor | 2 |
XlogP | 3.3 |
Synonyms | 2-[[4-[[2'-(2H-Tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl]-5-butyl-3,4-dihydro-3-oxo-2H-1,2,4-triazol]-2-yl]propanoic acid BDBM50044494 SCHEMBL9032521 2-{3-Butyl-5-oxo-4-[2''-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-4,5-dihydro-[1,2,4]triazol-1-yl}-propionic acid |
Inchi Key | AXEIUUWKJNJHAE-UHFFFAOYSA-N |
Inchi ID | InChI=1S/C23H25N7O3/c1-3-4-9-20-26-30(15(2)22(31)32)23(33)29(20)14-16-10-12-17(13-11-16)18-7-5-6-8-19(18)21-24-27-28-25-21/h5-8,10-13,15H,3-4,9,14H2,1-2H3,(H,31,32)(H,24,25,27,28) |
PubChem CID | 14956788 |
ChEMBL | CHEMBL315469 |
IUPHAR | N/A |
BindingDB | 50044494 |
DrugBank | N/A |
Structure | |
Lipinski's druglikeness | This ligand satisfies Lipinski's rule of five. |
Parameter | Value | Reference | Database source |
---|---|---|---|
IC50 | 26.0 nM | PMID8355255 | BindingDB,ChEMBL |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417